CNI-1493, an inhibitor of proinflammatory cytokines, retards cartilage destruction in rats with collagen induced arthritis

Annals of the Rheumatic Diseases

Volumn 64, Issue 3, 2005, Pages 494-496

  Larsson, E ^a   Harris, H E ^a   Palmblad, K ^a   Mansson B ^b   Saxne, T ^b   Klareskog, L ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; CARTILAGE OLIGOMERIC MATRIX PROTEIN; COLLAGEN; CYTOKINE; PLACEBO; SEMAPIMOD;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; CARTILAGE DEGENERATION; COLLAGEN INDUCED ARTHRITIS; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE COURSE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG INDUCED DISEASE; FEMALE; HISTOLOGY; JOINT DESTRUCTION; MONITORING; NONHUMAN; PRIORITY JOURNAL; RAT; SCORING SYSTEM;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, EXPERIMENTAL; BIOLOGICAL MARKERS; CARTILAGE, ARTICULAR; CYTOKINES; DISEASE PROGRESSION; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GLYCOPROTEINS; HYDRAZONES; IMMUNOSUPPRESSIVE AGENTS; RATS; STATISTICS, NONPARAMETRIC;

EID: 14144250623     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2004.021550     Document Type: Article

References (14)

1. Blanchi M, Ulrich P, Bloom O, Meistrell M. 3rd, Zimmerman GA, Schmidtmayerova H, et al. An inhibitor of macrophage arginine transport and nitric oxide production (CNI-1493) prevents acute inflammation and endotoxin lethality. Mol Med 1995;1:254-66.
2. Björk L, Tracev KJ, Ulrich P, Bianchi M, Cohen PS, Åkerlund K, et al. Targeted suppression or cytokine production in monocytes but not in T lymphocytes by a tetravalent guanylhydrazone (CNI-1493). J Infect Dis 1997;176:1303-12.
3. Åkerlund K, Erlandsson Harris H, Tracey KJ, Wang H, Fehniger T, et al. Anti-inflammatory effects of a new tumour necrosis factor-alpha (TNF-alpha) inhibitor (CNI-1493) in collagen-induced arthritis (CIA) in rats. Clin Exp Immunol 1999;115:32-41.
4. Hommes D, van den Blink B, Plasse T, Bartelsman J, Xu C, Macpherson B, et al. Inhibition of stress-activated MAP kinases induces clinical improvement in moderate to severe Crohn's disease. Gastroenterology 2002;122:7-14.
5. Larsson E, Müssener A, Heinegård D, Klareskog L, Saxne T. Increased serum levels of cartilage oligomeric matrix protein and bone sialoprotein in rats with collagen arthritis. Br J Rheumatol 1997;36:1258-61.
6. Smith BD, Martin GR, Miller EJ, Dorfman A, Swarm R. Nature of the collagen synthesized by a transplanted chondrosarcoma. Arch Biochem Biophys 1975;166:181-6.
7. Larsson P, Kleinau S, Holmdahl R, Klareskog L. Homologous type II collagen-induced arthritis in rats. Characterization of the disease and demonstration of clinically distinct forms of arthritis in two strains of rats after immunization with the same collagen preparation. Arthritis Rheum 1990;33:693-701.
8. Kleinau S, Erlandsson H, Holmdahl R, Klareskog L. Adjuvant oils induce arthritis in the DA rat. I. Characterization of the disease and evidence for an immunological involvement. J Autoimmun 1991;4:871-80.
9. Vingsbo-Lundberg C, Saxne T, Olsson H, Holmdahl R. Increased serum levels of cartilage oligomeric matrix protein in chronic erosive arthritis in rats. Arthritis Rheum 1998;41:544-50.
10. Joosten LA, Helsen MM, Saxne T, van De Loo FA, Heinegård D, van Den Berg WB. IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation. J Immunol 1999;163:5049-55.
11. Larsson E, Erlandsson Harris H, Larsson A, Mansson B, Saxne T, Klareskog L. Corticosteroid treatment of experimental arthritis retards cartilage destruction as determined by histology and serum COMP. Rheumatology (Oxford) 2004;43:428-34.
12. Cohen PS, Schmidtmayerova H, Dennis J, Dubrovsky L, Sherry B, Wang H, et al. The critical role of p38 MAP kinase in T cell HIV-1 replication. Mol Med 1997;3:339-46.
13. Bernik TR, Friedman SG, Ochani M, DiRaimo R, Ulloa L, Yang H, et al. Pharmacological stimulation of the cholinergic antiinflammatory pathway. J Exp Med 2002;195:781-8.
14. Feldmann M, Taylor P, Paleolog E, Brennan FM, Maini RN. Anti-TNF alpha therapy is useful in rheumatoid arthritis and Crohn's disease: analysis of the mechanism of action predicts utility in other diseases. Transplant Proc 1998;30:4126-7.